Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

Table 3 Multilevel linear regression of change in peritoneal solute transport rate in incident peritoneal dialysis patients

	Full model			Final model
Variable	Coefficient	Standard error	P values	Coefficient	Standard error	P values
Log₁₀ IL-6	0.02	0.006	0.002	0.02	0.006	0.004
PD solution
- Control	Reference	Reference	Reference	Reference	Reference	Reference
- Biocompatible	−0.05	0.02	0.005	−0.05	0.02	0.005
PD duration
- 12 month	Reference	Reference	Reference	Reference	Reference	Reference
- 24 month	0.05	0.01	<0.001	0.05	0.01	<0.001
Age	0.0002	0.0007	0.74
Male	−0.03	0.02	0.06
BMI (kg/m2):			0.11
- <20	Reference	Reference	Reference
- 20-24.9	0.03	0.06	0.59
- 25-30	0.02	0.06	0.71
- >30	0.07	0.06	0.25
Two-way interaction (PD duration*PD solution)^#	−0.04	0.01	0.008	−0.04	0.01	0.007
Ethnicity			0.31
- Caucasian	Reference	Reference	Reference
- Asian	−0.02	0.02	0.44
- ATSI	−0.08	0.05	0.09
- MPI	0.01	0.04	0.74

IL-6: Interleukin-6; PD: peritoneal dialysis; BMI: body mass index; ATSI: Aboriginal and Torres Strait Islander; MPI: Maori and Pacific Islander.
^#Represents interaction between month 12 and use of biocompatible PD solution use; interaction term from month 24 omitted because of collinearity.

ISSN: 1471-2369